CD Bioparticles

CD Bioparticles Introduces Functional Agarose Particles

CD Bioparticles proudly announces the launch of its new Functional Agarose Particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic ... READ MORE Posted October 23, 2024 at 12:44 AM

CD Bioparticles Announces Offering of Polystyrene Family Polymers

CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability. The polystyrene fami... READ MORE Posted September 05, 2024 at 02:23 AM

CD Bioparticles Announces New Line of Conjugated Agarose Particles

CD Bioparticles announces the launch of its new line of Conjugated Agarose Particles for researchers. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is excited to announce the launch of its new line of Conjugated Agarose Particles with various particle sizes (45-500 µm), designed to streamline protein purification workflows for researchers. These versatile particles offer a powerful solution for affinity separation and purification of protei... READ MORE Posted September 05, 2024 at 02:22 AM

CD Bioparticles Announces Versatile Basic Agarose Particles

CD Bioparticles announces new line of Basic Agarose Particles for efficient biomolecule separation. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the availability of its new line of Basic Agarose Particles for efficient biomolecule separation. These versatile, unmodified agarose microspheres offer researchers a powerful tool for various applications, including protein purification, negative controls in experiments, and the foundat... READ MORE Posted August 26, 2024 at 02:41 AM

CD BIOPARTICLES ANNOUNCES NEW LINE OF POLYACRYLAMIDES

CD Bioparticles is proud to announce the launch of its Polyacrylamides. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, announced the launch of its expanded line of low-PDI polymers, Polyacrylamides. The new product line offers different functional groups (e.g., acid, amine, and methoxy) and a variety of molecular weights (1.5 KDa-6,000 KDa), making them ideal for a wide range of applications, particularly for drug delivery. Low dispe... READ MORE Posted July 04, 2024 at 02:32 AM

CD BIOPARTICLES INTRODUCES INNOVATIVE AGAROSE PARTICLES

CD Bioparticles proudly announces the launch of its Agarose Particles for isolation and purification of proteins and antibodies. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its latest product line of Agarose Particles for isolation and purification of proteins and antibodies. These versatile microspheres, available in diameters ranging from 25 nm to 500 µm, empower researchers with a powerful tool for a wid... READ MORE Posted July 04, 2024 at 02:31 AM

The Mechanism of Adverse Immune Reactions of LNP-mRNA

Many clinical trials of mRNA-based drugs or vaccines have failed to successfully pass Phase I or Phase II. The reasons behind this are various, including low efficacy of candidate drugs and lower-than-expected clinical risk/treatment benefit profiles. Preclinical safety assessments aim to identify well-tolerated and efficacious LNP-mRNA formulations, and when toxicity is observed, in vivo, in vitro and ex vivo experiments aim to understand the underlying mechanisms an... READ MORE Posted June 06, 2024 at 01:31 AM

Polystyrene Particles Powering Miniaturized and Automated Immunoassays

Traditional immunoassays based on the format of 96-well microtiter plates are widely used in analytical laboratories and have become increasingly automated with the introduction of robotics technology in recent years, thereby enhancing assay throughput. Most clinical analyzers essentially operate as “stand-alone laboratories,” featuring precise, accurate, and highly reproducible programmatic liquid handling, sample addition, and washing steps. However, aside from cost, the size limitations of... READ MORE Posted June 06, 2024 at 01:28 AM

PLGA Nano Drug Carrier

Poly(lactic-co-glycolic acid) (PLGA) is a functional polymer organic compound randomly polymerized by lactic acid (PLA) and glycolic acid (PGA). It has been approved by the U.S. Food and Drug Administration It is certified by the Food and Drug Administration (FDA) and is a copolymer material available on the market. PLGA has good biocompatibility, biodegradability, mechanical strength, good plasticity, surface modification, and drug encapsulation. It has a wide range of uses in the field of b... READ MORE Posted May 09, 2024 at 11:07 PM

Colored Polystyrene Particles in Point-of-Care Diagnostics

What is POCT? Multiplexed point-of-care testing POCT (Point-of-Care Testing) refers to clinical and bedside testing conducted in close proximity to patients. It is often not performed by clinical laboratory personnel. POCT holds significant importance in disease prevention, etiology determination, prognosis, enhancing treatment outcomes, and reducing healthcare expenses. It meets clinical testing needs across various healthcare settings. POCT serves as a complement to traditional laboratory t... READ MORE Posted May 09, 2024 at 11:06 PM